Literature DB >> 7560810

Thyrotropin binding specificity for the thyrotropin receptor.

Y Nagayama1, H Yamasaki, A Takeshita, H Kimura, K Ashizawa, N Yokoyama, S Yamashita, B Rapoport, S Nagataki.   

Abstract

Recently, highly purified bovine thyrotropin (bTSH) of pituitary origin, as well as recombinant human (h) TSH free of lutropin (LH) contamination, has been reported to activate the LH/choriogonadotropin receptor (LH/CGR). These data challenge the concept of TSH specificity for its own receptor. We, therefore, re-evaluated these data using, as targets, the recombinant hTSH and rat LH/CGRs stably expressed in Chinese hamster ovary (CHO) cells. Partially purified bTSH (2 IU/mg protein) and, to a lesser degree, highly purified bTSH (30 IU/mg protein) increased intracellular cAMP levels in CHO-LH/CGR cells (an EC50 of 0.2 and > 20 mIU/ml, respectively). In contrast, recombinant hTSH (up to 1 IU/ml) did not. All three TSH preparations increased cAMP levels to the same extent in CHO-TSHR cells (an EC50 of 0.3 mIU/ml). Furthermore, we observed only nonspecific, low affinity TSH binding for CHO-LH/CGR cells and also for CHO cells transfected with the expression vector alone (a Kd of 100 nM), although both high and low affinity TSH binding was demonstrated in CHOT-SHR cells (a Kd of 0.3 and 100 nM, respectively). These data indicate that even highly purified bTSH of pituitary origin contains significant amounts of LH, and that TSH itself does not appear to activate the LH/CGR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560810     DOI: 10.1007/BF03347814

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Studies on the binding of radiolabeled thyrotropin to cultured human thyroid cells.

Authors:  M Yamamoto; B Rapoport
Journal:  Endocrinology       Date:  1978-12       Impact factor: 4.736

2.  Preparation of biologically active 125I-TSH.

Authors:  I D Goldfine; S M Amir; A W Petersen; S H Ingbar
Journal:  Endocrinology       Date:  1974-11       Impact factor: 4.736

3.  Doubts about human chorionic gonadotropin as a thyroid stimulator.

Authors:  R J Norman; C Lowings; T Oliver; T Chard
Journal:  Lancet       Date:  1985-05-11       Impact factor: 79.321

4.  In vitro responses to crude and purified hCG in human thyroid membranes.

Authors:  S M Amir; R C Sullivan; S H Ingbar
Journal:  J Clin Endocrinol Metab       Date:  1980-07       Impact factor: 5.958

5.  Extracellular domain chimeras of the TSH and LH/CG receptors reveal the mid-region (amino acids 171-260) to play a vital role in high affinity TSH binding.

Authors:  Y Nagayama; D Russo; G D Chazenbalk; H L Wadsworth; B Rapoport
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

6.  Thyroid-stimulatory effects of human chorionic gonadotrophin in early pregnancy. In vivo and in vitro studies.

Authors:  R L Kennedy; J Darne; H Griffiths; A Price; R Davies; M Cohn
Journal:  Horm Res       Date:  1990

7.  Interaction of human chorionic gonadotropin and human luteinizing hormone with human thyroid membranes.

Authors:  P Carayon; G Lefort; B Nisula
Journal:  Endocrinology       Date:  1980-06       Impact factor: 4.736

8.  Recombinant thyrotropin stimulates cAMP formation in CHO-K1 cells expressing recombinant chorionic gonadotropin receptor.

Authors:  K Gunji; T Endo; M Ohno; T Minegishi; T Onaya
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

9.  High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.

Authors:  Y Nagayama; A Takeshita; W Luo; K Ashizawa; N Yokoyama; S Nagataki
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

10.  Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

Authors:  Y Nagayama; H L Wadsworth; G D Chazenbalk; D Russo; P Seto; B Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.